Securities Code: 002872
Securities Abbreviation: ST TianSheng
Announcement Number: 2026-038
TianSheng Pharmaceutical Group Co., Ltd.
Announcement of Abnormal Stock Trading Fluctuations
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from any false records, misleading statements, or material omissions.
Special Notice:
-
Pursuant to Article 9.8.1, Item (VIII) of the Shenzhen Stock Exchange Stock Listing Rules, the Company's stock will be subject to an additional risk warning from September 15, 2025. According to relevant rules, the Company's application to lift this additional risk warning requires a period of twelve months from the date of the administrative penalty decision, and this matter is uncertain.
-
There have been no significant changes in the Company's fundamental operations recently. The Company's stock price may be subject to irrational speculation. Investors are advised to invest rationally and be aware of secondary market investment risks.
I. Abnormal Stock Trading Fluctuations
The stock of TianSheng Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") (Securities Code: 002872, Securities Abbreviation: ST TianSheng) experienced a cumulative closing price increase deviation of over 12% for three consecutive trading days (July 1, 2026, July 2, 2026, and July 3, 2026). In accordance with the relevant regulations of the Shenzhen Stock Exchange, the Company's stock trading is considered abnormal.